Rubius Therapeutics Income Tax

As of the most recent data (December 2022), RUBY shows a income tax of $54M. That compares with $10M in the prior-year period — up 415.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RUBY's income tax is now $54M (was $10M) — a 415.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Rubius Therapeutics is outperforming or lagging.

Tracking RUBY's income tax over time shows whether Rubius Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $54M That compares with $10M in the prior-year period — up 415.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this income tax page, Stockcircle has Rubius Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect income tax (currently $54M) with ownership activity and broader fundamentals.

Rubius Therapeutics's income tax is $54M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.